Best of ASCO® Toronto 2024: GI Cancer – Dr. Elena Elimova

Best of ASCO® Toronto 2024: GI Cancer – Dr. Elena Elimova

Chicago Highlights 2024 Roundtable Discussions
Icon Chair Speaker

Co-Chairs

Dr. Aly-Khan Lalani
Dr. Natasha Leighl

Icon Chair Speaker

Speakers

Dr. Elena Elimova

Studies/trials discussed:

  • MAGIC trial
  • CROSS trial
  • FLOT-4 trial
  • Neo-AEGIS trial
  • ESOPEC trial
  • Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial)
  • CHECKMATE-577 trial
  • TOPGEAR trial
  • TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
  • TRANSMET trial
  • Chemotherapy and liver transplantation versus chemotherapy alone in patients with definitively unresectable colorectal liver metastases: A prospective multicentric randomized trial (TRANSMET)
  • Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial
  • COLLISION trial
  • Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial
  • PASS-01 trial
  • GIANT study
  • The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer defining a new treatment option for older vulnerable patients
  • Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study
  • A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186
Tagged